Valicenti Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,280
Closed -$4.99M 84
2025
Q3
$4.99M Buy
10,280
+35
+0.3% +$16.3K 1.07% 27
2025
Q2
$4.15M Buy
10,245
+127
+1% +$53.1K 0.97% 29
2025
Q1
$5.04M Buy
10,118
+332
+3% +$180K 1.29% 26
2024
Q4
$5.09M Sell
9,786
-357
-4% -$196K 1.27% 25
2024
Q3
$6.27M Sell
10,143
-147
-1% -$87K 1.61% 22
2024
Q2
$5.69M Buy
10,290
+3,868
+60% +$2.22M 1.53% 21
2024
Q1
$3.73M Buy
6,422
+52
+0.8% +$29.2K 1.04% 29
2023
Q4
$3.38M Buy
6,370
+1,078
+20% +$522K 1.03% 29
2023
Q3
$2.68M Buy
+5,292
New +$2.82M 0.91% 33

Other funds holding TMO

Valicenti Advisory Services's TMO Position: Q4 2025 in Review

Valicenti Advisory Services sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 10,280 shares — an estimated $4.99M sold.

Valicenti Advisory Services first reported a position in TMO in Q3 2023 and held it in 9 quarters. The position peaked at $6.27M in Q3 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Valicenti Advisory Services reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Valicenti Advisory Services sold 10,280 Thermo Fisher Scientific shares in Q4 2025, an estimated $4.99M.
  • Valicenti Advisory Services first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 9 quarters.
  • Valicenti Advisory Services's Thermo Fisher Scientific position peaked at $6.27M in Q3 2024.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Valicenti Advisory Services's 13F filing for Q4 2025, filed 16 Jan 2026.